Anti-Human CD40 [G28.5] In Vivo Antibody - Ultra Low Endotoxin
Introducing the Anti-Human CD40 [G28-5] In Vivo Antibody - Ultra Low Endotoxin from Assay Genie, a highly specific monoclonal antibody tailored for in vivo applications. This antibody targets the CD40 protein, a pivotal receptor in immune response regulation, making it ideal for research in immunology and related fields. With a mouse IgG1 isotype, it guarantees high purity and ultra-low endotoxin levels (<0.01 EU/μg), perfect for applications such as ELISA, flow cytometry, and in vivo functional assays. Available in various sizes, it is formulated in phosphate-buffered saline for stability and efficacy.
Elevate your research with this reliable and versatile antibody.
CD40 is a costimulatory protein found on antigen-presenting cells and is required for their activation. It plays a crucial role in activating the innate immune system, promoting tumor suppression, and regulating chronic inflammatory conditions. By interacting with its ligand CD40L, it enhances the immune response, making it vital for studies related to immune regulation, cancer immunotherapy, and autoimmune diseases.
Product Name:
Anti-Human CD40 (Clone G28.5) In Vivo Antibody - Ultra Low Endotoxin
Product Code:
IVMB0348
Size:
1 mg, 5 mg, 25 mg, 50 mg, 100 mg
Clone:
G28.5
Protein:
CD40
Product Type:
Monoclonal Antibody
Isotype:
IgG1 k
Reactivity:
Human
Applications:
FA, FC, In Vivo
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Endotoxin Level:
<0.5 EU/mg as determined by the LAL method
Purity:
≥98% monomer by analytical SEC â‹… >95% by SDS Page
Product Preparation:
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Applications:
FA, FC, In Vivo
Reactivity:
Human
Host Species:
Mouse
Specificity:
Clone G28.5 recognizes an epitope on human CD40
Antigen Distribution:
CD40 is widely expressed on antigen-presenting cells such as dendritic cells, B cells, macrophages, and monocytes, in addition to non-immune endothelial cells, basal epithelial cells, and a variety of tumors.
Endotoxin Level:
<0.5 EU/mg as determined by the LAL method
Formulation:
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (150 mM NaCl) PBS pH 7.2 - 7.4 with no carrier protein, potassium, calcium or preservatives added. Due to inherent biochemical properties of antibodies, certain products may be prone to precipitation over time. Precipitation may be removed by aseptic centrifugation and/or filtration.
Purity:
≥98% monomer by analytical SEC â‹… >95% by SDS Page
Preparation:
Functional grade preclinical antibodies are manufactured in an animal free facility using in vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling:
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
CD40 is a 48 kD type I transmembrane glycoprotein that is a member of the TNFR superfamily. CD40, in association with its ligand CD154 (CD40L) - a 39 kD protein, acts as a costimulatory molecule for the activation of B cells, dendritic cells, monocytes, and other antigen presenting cells. CD40 is involved in Ig isotype switching and dendritic cell maturation, as well as the activation, differentiation and proliferation of B cells. CD40 interacts with TNFR2 and is involved in the regulation of signal transduction. CD40 is a potential target for cancer immunotherapy. Blocking the interaction of CD40 with its ligand (CD154) is the sought-after therapeutic objective for preventing and/or improving both autoimmune diseases and transplant rejection. Studies have shown that monoclonal antibodies that block CD154 in human clinical trials resulted in unanticipated vascular complications. Hence, an interest in the therapeutic potential for antagonist mAbs specific for human CD40 is emerging. Antibodies of particular therapeutic interest are those that do not inhibit CD40 signaling via physical competition with CD154. Additionally, the interaction of CD40 and its ligand (CD154) is found to be essential for amyloid-beta-induced microglial activation, thus plays a significant part in Alzheimer disease pathogenesis.
To protect mouse colonies from infection by pathogens and to assure that experimental preclinical data is not affected by such pathogens, all of Assay Genie's Purified Functional Antibodies are tested and guaranteed to be negative for all pathogens in the IDEXX IMPACT I Mouse Profile.
![Anti-Human CD40 [G28.5] In Vivo Antibody - Low Endotoxin](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/214348/569352/anti-human-cd40-g28.5-in-vivo-antibody-low-endotoxin__55086.1673496638.jpg?c=2 "Anti-Human CD40 [G28.5] In Vivo Antibody - Low Endotoxin")
![Anti-Mouse CD40 [FGK45] In Vivo Antibody - Ultra Low Endotoxin](https://cdn11.bigcommerce.com/s-h68l9z2lnx/images/stencil/590x590/products/214488/569508/anti-mouse-cd40-fgk45-in-vivo-antibody-ultra-low-endotoxin__78080.1673497122.jpg?c=2 "Anti-Mouse CD40 [FGK45] In Vivo Antibody - Ultra Low Endotoxin")
